254 related articles for article (PubMed ID: 23902161)
1. A prospective 14-year longitudinal follow-up of dementia in persons with Down syndrome.
McCarron M; McCallion P; Reilly E; Mulryan N
J Intellect Disabil Res; 2014 Jan; 58(1):61-70. PubMed ID: 23902161
[TBL] [Abstract][Full Text] [Related]
2. A prospective 20-year longitudinal follow-up of dementia in persons with Down syndrome.
McCarron M; McCallion P; Reilly E; Dunne P; Carroll R; Mulryan N
J Intellect Disabil Res; 2017 Sep; 61(9):843-852. PubMed ID: 28664561
[TBL] [Abstract][Full Text] [Related]
3. Fifteen-year follow-up of 92 hospitalized adults with Down's syndrome: incidence of cognitive decline, its relationship to age and neuropathology.
Margallo-Lana ML; Moore PB; Kay DW; Perry RH; Reid BE; Berney TP; Tyrer SP
J Intellect Disabil Res; 2007 Jun; 51(Pt. 6):463-77. PubMed ID: 17493029
[TBL] [Abstract][Full Text] [Related]
4. Survival in elderly persons with Down syndrome.
Coppus AM; Evenhuis HM; Verberne GJ; Visser FE; Oostra BA; Eikelenboom P; van Gool WA; Janssens AC; van Duijn CM
J Am Geriatr Soc; 2008 Dec; 56(12):2311-6. PubMed ID: 19093931
[TBL] [Abstract][Full Text] [Related]
5. The prevalence and incidence of mental ill-health in adults with Down syndrome.
Mantry D; Cooper SA; Smiley E; Morrison J; Allan L; Williamson A; Finlayson J; Jackson A
J Intellect Disabil Res; 2008 Feb; 52(Pt 2):141-55. PubMed ID: 18197953
[TBL] [Abstract][Full Text] [Related]
6. The Adaptive Behaviour Dementia Questionnaire (ABDQ): screening questionnaire for dementia in Alzheimer's disease in adults with Down syndrome.
Prasher V; Farooq A; Holder R
Res Dev Disabil; 2004; 25(4):385-97. PubMed ID: 15193672
[TBL] [Abstract][Full Text] [Related]
7. Association of Dementia With Mortality Among Adults With Down Syndrome Older Than 35 Years.
Hithersay R; Startin CM; Hamburg S; Mok KY; Hardy J; Fisher EMC; Tybulewicz VLJ; Nizetic D; Strydom A
JAMA Neurol; 2019 Feb; 76(2):152-160. PubMed ID: 30452522
[TBL] [Abstract][Full Text] [Related]
8. Early age at menopause is associated with increased risk of dementia and mortality in women with Down syndrome.
Coppus AM; Evenhuis HM; Verberne GJ; Visser FE; Eikelenboom P; van Gool WA; Janssens AC; van Duijn CM
J Alzheimers Dis; 2010; 19(2):545-50. PubMed ID: 20110600
[TBL] [Abstract][Full Text] [Related]
9. Depressive symptoms, vascular disease, and mild cognitive impairment: findings from the Cardiovascular Health Study.
Barnes DE; Alexopoulos GS; Lopez OL; Williamson JD; Yaffe K
Arch Gen Psychiatry; 2006 Mar; 63(3):273-9. PubMed ID: 16520432
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic instruments for dementia in older people with intellectual disability in clinical practice.
Strydom A; Hassiotis A
Aging Ment Health; 2003 Nov; 7(6):431-7. PubMed ID: 14578004
[TBL] [Abstract][Full Text] [Related]
11. The modified CAMDEX informant interview is a valid and reliable tool for use in the diagnosis of dementia in adults with Down's syndrome.
Ball SL; Holland AJ; Huppert FA; Treppner P; Watson P; Hon J
J Intellect Disabil Res; 2004 Sep; 48(Pt 6):611-20. PubMed ID: 15312062
[TBL] [Abstract][Full Text] [Related]
12. [Dementia following bipolar disorder].
Lebert F; Lys H; Haëm E; Pasquier F
Encephale; 2008 Dec; 34(6):606-10. PubMed ID: 19081458
[TBL] [Abstract][Full Text] [Related]
13. Dementia and mortality in persons with Down's syndrome.
Coppus A; Evenhuis H; Verberne GJ; Visser F; van Gool P; Eikelenboom P; van Duijin C
J Intellect Disabil Res; 2006 Oct; 50(Pt 10):768-77. PubMed ID: 16961706
[TBL] [Abstract][Full Text] [Related]
14. A 10-year follow-up of hippocampal volume on magnetic resonance imaging in early dementia and cognitive decline.
den Heijer T; van der Lijn F; Koudstaal PJ; Hofman A; van der Lugt A; Krestin GP; Niessen WJ; Breteler MM
Brain; 2010 Apr; 133(Pt 4):1163-72. PubMed ID: 20375138
[TBL] [Abstract][Full Text] [Related]
15. Annual rate and predictors of conversion to dementia in subjects presenting mild cognitive impairment criteria defined according to a population-based study.
Amieva H; Letenneur L; Dartigues JF; Rouch-Leroyer I; Sourgen C; D'Alchée-Birée F; Dib M; Barberger-Gateau P; Orgogozo JM; Fabrigoule C
Dement Geriatr Cogn Disord; 2004; 18(1):87-93. PubMed ID: 15087583
[TBL] [Abstract][Full Text] [Related]
16. Neopterin and the risk of dementia in persons with Down syndrome.
Coppus AM; Fekkes D; Verhoeven WM; Evenhuis HM; van Duijn CM
Neurosci Lett; 2009 Jul; 458(2):60-4. PubMed ID: 19442877
[TBL] [Abstract][Full Text] [Related]
17. The relationship between acquired impairments of executive function and behaviour change in adults with Down syndrome.
Adams D; Oliver C
J Intellect Disabil Res; 2010 May; 54(5):393-405. PubMed ID: 20367747
[TBL] [Abstract][Full Text] [Related]
18. The triple challenges associated with age-related comorbidities in Down syndrome.
Glasson EJ; Dye DE; Bittles AH
J Intellect Disabil Res; 2014 Apr; 58(4):393-8. PubMed ID: 23510031
[TBL] [Abstract][Full Text] [Related]
19. Five-year follow-up of cognitive impairment with no dementia.
Tuokko H; Frerichs R; Graham J; Rockwood K; Kristjansson B; Fisk J; Bergman H; Kozma A; McDowell I
Arch Neurol; 2003 Apr; 60(4):577-82. PubMed ID: 12707072
[TBL] [Abstract][Full Text] [Related]
20. The impact of apolipoprotein E on dementia in persons with Down's syndrome.
Coppus AM; Evenhuis HM; Verberne GJ; Visser FE; Arias-Vasquez A; Sayed-Tabatabaei FA; Vergeer-Drop J; Eikelenboom P; van Gool WA; van Duijn CM
Neurobiol Aging; 2008 Jun; 29(6):828-35. PubMed ID: 17250929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
